Lotus Reports First-Half Results for Fiscal Year 2022
VANCOUVER, BC / ACCESSWIRE / April 29, 2022 / Lotus Ventures Inc. (CSE:J)(OTC PINK:LTTSF) ("Lotus" or the "Company"), a premium...
Day: April 29, 2022
Neovasc to Report First Quarter Financial Results on May 12, 2022
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - April 29, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN), will report financial...
B-Secur’s EKG Cloud Tech Improves Accuracy in Heart Health Monitoring
FDA-cleared HeartKey® 2.0 launches to power next generation of medical and consumer devices and platforms SAN FRANCISCO--(BUSINESS WIRE)--Global heart health...
HST Pathways Announces Acquisition of Simplify ASC
This acquisition further underscores HST’s longstanding commitment to enhancing ASC technology and delivering improved patient outcomes across the industry. NASHVILLE--(BUSINESS...
Moderna Files to Expand Conditional Marketing Authorization for Its COVID-19 Vaccine to Include Children Six Months to Under Six Years in The European Union
The filing follows the European Medicines Agency's Committee for Medicinal Products for Human Use recent decision to adopt a positive...
Moderna Finalizes Plan for Long-Term Strategic Partnership with The Government of Canada
Onshore manufacturing facility is expected to be based in Quebec and produce up to 100 million mRNA respiratory vaccine doses...
CORRECTION: Cloud DX Announces Investor Event to Recap Financials and Q1 Growth
This replaces and corrects a release that ran earlier in the week.KITCHENER, ON / ACCESSWIRE / April 29, 2022 /...
Avinger to Announce First Quarter 2022 Results on May 10
REDWOOD CITY, CA / ACCESSWIRE / April 29, 2022 / Avinger, Inc. (Nasdaq:AVGR), commercial-stage medical device company marketing the first...
Nutriband Inc. Reports Revenue Up 56% in Fiscal 2022 to a Record $1.4M
ORLANDO, FL / ACCESSWIRE / April 29, 2022 / Nutriband Inc. (NASDAQ:NTRB), a developer of transdermal pharmaceutical products, today announced...
Dr. Gregg Sturrus’ TEDx Talk(R) Features Halberd’s Extracorporeal Treatment of Neurodegenerative Diseases
JACKSON CENTER, PA / ACCESSWIRE / April 29, 2022 / A key member of Halberd Corporation's (OTC PINK:HALB) Research Team,...
Abeona Therapeutics Announces Presentation at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
NEW YORK and CLEVELAND, April 29, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in cell...
HEXO Announces Leadership Transition; Company Appoints Charlie Bowman as Chief Executive Officer and Julius Ivancsits as Chief Financial Officer
Scott Cooper Steps Down; Board of Directors Acknowledge Cooper in Stabilizing the Company Bowman and Ivancsits to Lead HEXO’s Continued...
Galecto Reports First Quarter Operating and Financial Results
BOSTON, April 29, 2022 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development...
Coherus BioSciences to Report First Quarter 2022 Financial Results on May 5th, 2022
REDWOOD CITY, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its first quarter...
Enlivex Announces Full Year 2021 Financial Results, Completion of Development of Frozen Formulation Allocetra™ Ahead of Schedule, and Provides Strategic & Business Updates
Development of frozen formulation Allocetra™, a primary cornerstone of Enlivex’s R&D efforts during the last two years, was successfully completed...
ReWalk Joins Israeli Technology Innovation Consortium for Human-Robot Interaction
The MAGNET Consortium program led by Israel’s Innovation Authority fosters collaboration through R&D grantsMARLBOROUGH, Mass., April 29, 2022 (GLOBE NEWSWIRE)...
Nass Valley Gardens Inc. Announces It Will Diversify Its Product Offering Which Will Include a Cosmetic Line and Hemp-Based Foods
WEST PALM BEACH, FL, April 29, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nass Valley Gardens Inc., a Nevada registered C-Corp and...
U.S. Food and Drug Administration Approves Camzyos (mavacamten) for the Treatment of Adults with Symptomatic New York Heart Association Class II-III Obstructive Hypertrophic Cardiomyopathy (HCM) to Improve Functional Capacity and Symptoms
LianBio to Continue Development of Camzyos in China and Other Asian TerritoriesSHANGHAI and PRINCETON, N.J., April 29, 2022 (GLOBE NEWSWIRE)...
Palisade Bio to Participate in the Virtual Investor Management and KOL Roundtable Event
Live moderated video webcast discussion among members of Management and a renowned Key Opinion Leader on Tuesday, May 3rd at...
Amedisys to Present at Multiple Healthcare Conferences in May
BATON ROUGE, La., April 29, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice,...